Oritavancin in vitro activity against Gram-positive organisms from European medical centers: a 10-year longitudinal overview from the SENTRY Antimicrobial Surveillance Program (2010-2019).
Saved in:
| Title: | Oritavancin in vitro activity against Gram-positive organisms from European medical centers: a 10-year longitudinal overview from the SENTRY Antimicrobial Surveillance Program (2010-2019). |
|---|---|
| Authors: | Pfaller MA; JMI Laboratories, North Liberty, IA, USA.; Department of Pathology, University of Iowa College of Medicine, Iowa City, IA, USA., Mendes RE; JMI Laboratories, North Liberty, IA, USA., Sader HS; JMI Laboratories, North Liberty, IA, USA., Castanheira M; JMI Laboratories, North Liberty, IA, USA., Carvalhaes CG; JMI Laboratories, North Liberty, IA, USA. |
| Source: | Journal of chemotherapy (Florence, Italy) [J Chemother] 2023 Dec; Vol. 35 (8), pp. 689-699. Date of Electronic Publication: 2023 Nov 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 8907348 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1973-9478 (Electronic) Linking ISSN: 1120009X NLM ISO Abbreviation: J Chemother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1973-9478 |
|---|---|
| DOI: | 10.1080/1120009X.2023.2259673 |
